
Senators lead call for CMS to fairly evaluate Alzheimer’s treatments
The Centers for Medicare and Medicaid Services proposes to cover an entire class of Alzheimer’s drugs only if beneficiaries are enrolled in a randomized control trial conducted in an outpatient hospital setting.








